Gijs Limonard

823 total citations · 1 hit paper
17 papers, 556 citations indexed

About

Gijs Limonard is a scholar working on Public Health, Environmental and Occupational Health, Parasitology and Infectious Diseases. According to data from OpenAlex, Gijs Limonard has authored 17 papers receiving a total of 556 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Public Health, Environmental and Occupational Health, 6 papers in Parasitology and 5 papers in Infectious Diseases. Recurrent topics in Gijs Limonard's work include Vector-borne infectious diseases (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Pleural and Pulmonary Diseases (4 papers). Gijs Limonard is often cited by papers focused on Vector-borne infectious diseases (6 papers), SARS-CoV-2 and COVID-19 Research (4 papers) and Pleural and Pulmonary Diseases (4 papers). Gijs Limonard collaborates with scholars based in Netherlands, Germany and United States. Gijs Limonard's co-authors include Gilbert J. Kersh, Christopher D. Paddock, Alicia D. Anderson, Pierre‐Edouard Fournier, Jennifer H. McQuiston, Daniel J. Sexton, Thomas J. Marrie, Joshua D. Hartzell, H. A. Bijlmer and Stephen Graves and has published in prestigious journals such as PLoS ONE, CHEST Journal and Frontiers in Immunology.

In The Last Decade

Gijs Limonard

17 papers receiving 538 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group.

2013 342 citations Alicia D. Anderson, H. A. Bijlmer et al. PubMed profile →

Peers

Countries citing papers authored by Gijs Limonard

Since Specialization

Citations

This map shows the geographic impact of Gijs Limonard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gijs Limonard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gijs Limonard more than expected).

Fields of papers citing papers by Gijs Limonard

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gijs Limonard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gijs Limonard. The network helps show where Gijs Limonard may publish in the future.

Co-authorship network of co-authors of Gijs Limonard

This figure shows the co-authorship network connecting the top 25 collaborators of Gijs Limonard. A scholar is included among the top collaborators of Gijs Limonard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gijs Limonard. Gijs Limonard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

17 of 17 papers shown

#	Work	Indexed citations
1	Differential abundance of IgG antibodies against the spike protein of SARS-CoV-2 and seasonal coronaviruses in patients with fatal COVID-19 2023 ·Virology Journal ·Wouter L. Smit, Sophie van Tol, Lenneke Haas, Gijs Limonard, Ailko Bossink, Chantal Reusken, Michiel Heron, Steven Thijsen	3
2	Impaired SARS-CoV-2 specific T-cell response in patients with severe COVID-19 2023 ·Frontiers in Immunology ·(unknown), Wouter L. Smit, Ailko Bossink, Gijs Limonard, Danya Muilwijk, Lenneke Haas, Chantal Reusken, (unknown), (unknown), (unknown), Hendrik Gremmels, Jeffrey M. Beekman, Monique Nijhuis, Annemarie M. J. Wensing, Michiel Heron, Steven Thijsen	6
3	Heterologous Immune Responses of Serum IgG and Secretory IgA Against the Spike Protein of Endemic Coronaviruses During Severe COVID-19 2022 ·Frontiers in Immunology ·Wouter L. Smit, Sophie van Tol, (unknown), (unknown), (unknown), (unknown), Gijs Limonard, Ailko Bossink, Gert-Jan Godeke, (unknown), Johan Reimerink, Dirk Eggink, Chantal Reusken, Michiel Heron, Steven Thijsen	8
4	Differential vaccine-induced kinetics of humoral and cellular immune responses in SARS-CoV-2 naive and convalescent health care workers 2022 ·Pathogens and Disease ·Wouter L. Smit, Steven Thijsen, (unknown), Sophie van Tol, Johan Reimerink, Chantal Reusken, (unknown), Ailko Bossink, Gijs Limonard, Michiel Heron	4
5	Addison’s Disease Caused by Tuberculosis: Diagnostic and Therapeutic Difficulties 2018 ·European Journal of Case Reports in Internal Medicine ·(unknown), Hannah Visser, Alex F. Muller, Gijs Limonard	12
6	Persistence of impaired health status of Q fever patients 4 years after the first Dutch outbreak 2015 ·Epidemiology and Infection ·Gijs Limonard, Jeannette B. Peters, (unknown), (unknown), P.N.R. Dekhuijzen, Jan H. Vercoulen, Marrigje H. Nabuurs-Franssen	8
7	Clinical relevance ofCorynebacterium pseudodiphtheriticumin lower respiratory tract specimens 2015 ·Infectious Diseases ·(unknown), Steven Thijsen, Sanjay U. C. Sankatsing, Gijs Limonard	11
8	Diagnosis of Coxiella burnetii Infection: Comparison of a Whole Blood Interferon-Gamma Production Assay and a Coxiella ELISPOT 2014 ·PLoS ONE ·Teske Schoffelen, Gijs Limonard, Chantal P. Bleeker‐Rovers, John J. M. Bouwman, J.W.M. van der Meer, Marrigje H. Nabuurs-Franssen, Tom Sprong, Marcel van Deuren	8
9	Diagnosis and management of Q fever--United States, 2013: recommendations from CDC and the Q Fever Working Group. breakdown → 2013 ·PubMed ·Alicia D. Anderson, H. A. Bijlmer, Pierre‐Edouard Fournier, Stephen Graves, Joshua D. Hartzell, Gilbert J. Kersh, Gijs Limonard, Thomas J. Marrie, Robert F. Massung, Jennifer H. McQuiston, William L. Nicholson, Christopher D. Paddock, Daniel J. Sexton	342
10	Developing a new clinical tool for diagnosing chronic Q fever: theCoxiellaELISPOT: Table 1 2011 ·FEMS Immunology & Medical Microbiology ·Gijs Limonard, Steven Thijsen, Aik Bossink, (unknown), John J. M. Bouwman	15
11	One-year follow-up of patients of the ongoing Dutch Q fever outbreak: clinical, serological and echocardiographic findings 2010 ·Infection ·Gijs Limonard, Marrigje H. Nabuurs-Franssen, G. Weers-Pothoff, Clementine Wijkmans, (unknown), A. M. Horrevorts, Peter M. Schneeberger, (unknown)	49
12	Detailed analysis of health status of Q fever patients 1 year after the first Dutch outbreak: a case-control study 2010 ·QJM ·Gijs Limonard, Jeannette B. Peters, Marrigje H. Nabuurs-Franssen, G. Weers-Pothoff, (unknown), (unknown), P.N.R. Dekhuijzen, Jan H. Vercoulen	29
13	Diagnostic Value of Histology Compared With Cytology in Transbronchial Aspiration Samples Obtained by Histology Needle 2010 ·Journal of Bronchology & Interventional Pulmonology ·(unknown), Gijs Limonard, Brigiet M. Hoevenaars, (unknown), J. Janssen	3
14	Pleural FDG Uptake More Than a Decade after Talc Pleurodesis 2009 ·Case Reports in Medicine ·(unknown), Wouter van der Bruggen, Gijs Limonard	23
15	A 37-Year-Old Woman With an Incidentally Found Mediastinal Nodule 2008 ·CHEST Journal ·Gijs Limonard, (unknown), (unknown), (unknown), (unknown), (unknown)	1
16	Learning Curve of Conventional Transbronchial Needle Aspiration in Pulmonologists Experienced in Bronchoscopy 2007 ·Respiration ·(unknown), Gijs Limonard, (unknown), (unknown), (unknown), Bernard Hol, J. Janssen	29
17	Necessary resection of the left lower lobe due to systemic arterial supply 2007 ·Journal of Thoracic and Cardiovascular Surgery ·(unknown), (unknown), Gijs Limonard, (unknown)	5

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact